Page 9 - Company Expanded Access Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

RedHill Biopharma Announces $6 Million Registered Direct Offering

/PRNewswire/ RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered.

United kingdomNew yorkUnited statesAdi frishRedhill biopharmaExchange commissionCorporate business developmentRedhill biopharma ltdCompany expanded access programCompany annual report on formCompany american depositary shares adssHc wainwright coAmerican depositary sharesHill biopharmaPrivate securities litigation reform actExpanded access program

RedHill Biopharma Announces Plan to Implement ADS Ratio Change

/PRNewswire/ RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it plans to.

United kingdomRedhill biopharmaAdi frishCompany american depositary shares adssCompany adssRedhill biopharma ltdExchange commissionCompany annual report on formCompany expanded access programNasdaq stock marketBusiness developmentHill biopharmaAmerican depositary sharesNasdaq global marketNew york mellonNasdaq listing rule

RedHill Biopharma Announces Plan to Implement ADS Ratio Change

RedHill Biopharma Announces Plan to Implement ADS Ratio Change
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomRedhill biopharmaAdi frishCompany american depositary shares adssCompany adssRedhill biopharma ltdExchange commissionCompany annual report on formCompany expanded access programNasdaq stock marketBusiness developmentPrnewswire redhill biopharma ltdHill biopharmaAmerican depositary sharesNasdaq global marketNew york mellon

RedHill Biopharma Announces Definitive Agreement for Up To $6 Million Private Placement with a Single Investor

/PRNewswire/ RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced agreement, with a.

United kingdomUnited statesRedhill biopharmaAdi frishAdss of the companyCompany adssRedhill biopharma ltdExchange commissionCompany annual report on formCompany expanded access programBusiness developmentHill biopharmaAmerican depositary sharesSecurities actPrivate securities litigation reform actExpanded access program

RedHill s Opaganib Selected by the NIH Radiation and Nuclear Countermeasures Program

The National Institutes of Health s (NIH) Radiation and Nuclear Countermeasures Program (RNCP) has selected opaganib for testing via their radiation medical.

United kingdomDror ben asherRedhill biopharmaAdi frishNuclear countermeasures programNational institute of allergyRedhill biopharma ltdCompany annual report on formProduct developmentCompany expanded access programProduct development pipelinePrnewswire redhill biopharma ltdNational institutes of healthDrug administrationExchange commissionInternational journal of molecular sciences